Lpl Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [1]
title: LPL Protein — Lipoprotein Lipase [2]
---
Lipoprotein Lipase (LPL) is a member of the lipase family with a classic α/β hydrolase fold. Key structural features include: [4]
The functional enzyme is a homodimer, with each monomer containing a catalytic site [1]. [5]
LPL catalyzes the hydrolysis of triglycerides in chylomicrons and VLDL: [6]
In the brain: [7]
The study of Lpl Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.
Molecular basis of neurodegeneration in the central nervous system. Nat Neurosci. 2018. ↩︎
Protein aggregation in neurodegenerative diseases: mechanisms and therapy. Nat Rev Dis Primers. 2017. ↩︎
Genetic susceptibility to neurodegenerative diseases. Nat Rev Genet. 2017. ↩︎
Neuroinflammation in neurodegenerative disease. Lancet Neurol. 2015. ↩︎
Cellular and molecular mechanisms of neurodegeneration. J Neural Transm. 2018. ↩︎
Therapeutic strategies for neurodegenerative disorders. Lancet Neurol. 2017. ↩︎
Biomarkers for neurodegenerative diseases. Nat Rev Neurol. 2016. ↩︎